Bisher 59 Fälle von Hirnthrombosen nach Astrazeneca-Impfung
Covid19-Sources
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Global dynamic spatiotemporal pattern of seasonal influenza since 2009 influenza pandemic
Relative humidity in droplet and airborne transmission of disease
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells | medRxiv
Sterbefallzahlen während der Corona-Pandemie – neue Methoden und aktuelle Ergebnisse - Statistisches Bundesamt
25_Mar_2021_Short_Paper_Ventilation_Occupancy_Parameters - 2021.04.21.21255898v1.full.pdf
Search VAERS Database
6-Month Follow Up of 8679 Hospitalized COVID-19 Patients in Germany: A Nationwide Cohort Study | medRxiv
Project reveals asymptomatic spread of COVID-19 in schools | UNMC
COVID-19 and the Political Economy of Mass Hysteria
Children from 5 schools among Israel's 41 cases of Indian COVID strain | The Times of Israel
Eurosurveillance | Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021
Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study - 2021.04.27.21256163v1.full.pdf
Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity | bioRxiv
SARS-CoV-2 induced cytopathic effect
Late conditions diagnosed 1–4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data — United States, March 1–June 30, 2020 | Clinical Infectious Diseases | Oxford Academic
Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine | medRxiv
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1) - International Journal of Infectious Diseases
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19 - ScienceDirect
Kaum schwere Verläufe: Kreuzimmunität durch Corona-Vorinfektion - n-tv.de
Studie: Tübinger Modellprojekt hat zu mehr Ansteckungen mit SARS-CoV-2...
Attributes and predictors of long COVID | Nature Medicine
Generation of a Sleeping Beauty transposon-based cellular system for rapid and sensitive identification of SARS-CoV-2 host dependency and restriction factors | bioRxiv
Sars-CoV-2 kann die Bauchspeicheldrüse schädigen - Hormone - derStandard.at › Gesundheit
Post-acute COVID-19 outcomes in children with mild and asymptomatic disease - The Lancet Child & Adolescent Health
SARS-CoV-2 Infection after Vaccination in Health Care Workers in California | NEJM
Adenoviruses in the immunocompromised host - PubMed
SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties - The Lancet
How Pfizer Makes Its Covid-19 Vaccine - The New York Times